The incidence of, and risk factors for, liver injury in adults living with human immunodeficiency virus initiating antiretroviral therapy in a South African private sector managed care cohort

Simple item page
dc.contributor.advisorDe Waal, Renee
dc.contributor.advisorCohen, Karen
dc.contributor.advisorMouton, Johannes
dc.contributor.authorSinha, Suniti
dc.date.accessioned2026-05-08T08:14:31Z
dc.date.available2026-05-08T08:14:31Z
dc.date.issued2023
dc.date.updated2026-05-08T07:35:59Z
dc.description.abstractIntroduction Hospital surveys found that drug-induced liver injury is a leading adverse reaction resulting in hospitalization and death in people living with HIV (PLHIV) in South Africa. Objectives To determine incidence of, and risk factors for, liver injury and liver injury-related hospitalizations in PLHIV on antiretroviral treatment (ART). Methods We described the incidence of, and associations with, ALT³120 IU/L, ALT³200 IU/L, and hospitalizations with raised ALT in PLHIV aged >18 years in the Aid for AIDS private sector cohort (comprising medical scheme beneficiaries) commencing ART between 2011–2018. Results We included 92,757 PLHIV; median age was 38.4 years; 42.5% were male, and 88.6% were on efavirenz-based ART. Incidence per 100 person years (95% confidence interval (CI)) of ALT³120IU/L, ALT³200IU/L, hospitalization with ALT³120IU/L, and hospitalization with ALT³200IU/L was 0.93 (0.89-0.97), 0.38 (0.36-0.41), 0.06 (0.05-0.07), and 0.04 (0.03-0.05), respectively. Adjusted hazard ratios (aHRs) (95% CI) for ALT³120IU/L and hospitalization with ALT≥120IU/L respectively were 15.3 (12.1-19.3) and 6.27 (3.11-12.6) for antituberculosis drug exposure; 1.63 (1.31-2.02) and 1.50 (0.70-3.20) for efavirenz; and 2.74 (2.04-3.69) and 3.48 (1.24-9.73) for nevirapine, compared to protease inhibitors. AHRs (95%CI) for ALT³200IU/L and hospitalization with ALT≥200IU/L respectively were 12.6 (9.31-17.1) and 5.68 (2.58-12.5) for antituberculosis drug exposure; 1.74 (1.28-2.37) and 1.97 (0.69-5.58) for efavirenz; and 3.01 (1.97-4.61) and 3.56 (0.93-13.65) for nevirapine. Suniti Sinha SNHSUN002 All HRs adjusted for age, sex, CD4 count and viral load at ART initiation, and alcohol-induced pathology. Conclusions Exposure to antituberculosis drugs was strongly associated with liver injury. Safer antituberculosis treatment regimens are needed for PLHIV.
dc.identifier.apacitationSinha, S. (2023). <i>The incidence of, and risk factors for, liver injury in adults living with human immunodeficiency virus initiating antiretroviral therapy in a South African private sector managed care cohort</i>. (). University of Cape Town ,Faculty of Health Sciences ,Department of Public Health and Family Medicine. Retrieved from http://hdl.handle.net/11427/43203en_ZA
dc.identifier.chicagocitationSinha, Suniti. <i>"The incidence of, and risk factors for, liver injury in adults living with human immunodeficiency virus initiating antiretroviral therapy in a South African private sector managed care cohort."</i> ., University of Cape Town ,Faculty of Health Sciences ,Department of Public Health and Family Medicine, 2023. http://hdl.handle.net/11427/43203en_ZA
dc.identifier.citationSinha, S. 2023. The incidence of, and risk factors for, liver injury in adults living with human immunodeficiency virus initiating antiretroviral therapy in a South African private sector managed care cohort. . University of Cape Town ,Faculty of Health Sciences ,Department of Public Health and Family Medicine. http://hdl.handle.net/11427/43203en_ZA
dc.identifier.ris TY - Thesis / Dissertation AU - Sinha, Suniti AB - Introduction Hospital surveys found that drug-induced liver injury is a leading adverse reaction resulting in hospitalization and death in people living with HIV (PLHIV) in South Africa. Objectives To determine incidence of, and risk factors for, liver injury and liver injury-related hospitalizations in PLHIV on antiretroviral treatment (ART). Methods We described the incidence of, and associations with, ALT³120 IU/L, ALT³200 IU/L, and hospitalizations with raised ALT in PLHIV aged >18 years in the Aid for AIDS private sector cohort (comprising medical scheme beneficiaries) commencing ART between 2011–2018. Results We included 92,757 PLHIV; median age was 38.4 years; 42.5% were male, and 88.6% were on efavirenz-based ART. Incidence per 100 person years (95% confidence interval (CI)) of ALT³120IU/L, ALT³200IU/L, hospitalization with ALT³120IU/L, and hospitalization with ALT³200IU/L was 0.93 (0.89-0.97), 0.38 (0.36-0.41), 0.06 (0.05-0.07), and 0.04 (0.03-0.05), respectively. Adjusted hazard ratios (aHRs) (95% CI) for ALT³120IU/L and hospitalization with ALT≥120IU/L respectively were 15.3 (12.1-19.3) and 6.27 (3.11-12.6) for antituberculosis drug exposure; 1.63 (1.31-2.02) and 1.50 (0.70-3.20) for efavirenz; and 2.74 (2.04-3.69) and 3.48 (1.24-9.73) for nevirapine, compared to protease inhibitors. AHRs (95%CI) for ALT³200IU/L and hospitalization with ALT≥200IU/L respectively were 12.6 (9.31-17.1) and 5.68 (2.58-12.5) for antituberculosis drug exposure; 1.74 (1.28-2.37) and 1.97 (0.69-5.58) for efavirenz; and 3.01 (1.97-4.61) and 3.56 (0.93-13.65) for nevirapine. Suniti Sinha SNHSUN002 All HRs adjusted for age, sex, CD4 count and viral load at ART initiation, and alcohol-induced pathology. Conclusions Exposure to antituberculosis drugs was strongly associated with liver injury. Safer antituberculosis treatment regimens are needed for PLHIV. DA - 2023 DB - OpenUCT DP - University of Cape Town KW - Drug Safety journal KW - Pharmacoepidemiology KW - HIV LK - https://open.uct.ac.za PB - University of Cape Town PY - 2023 T1 - The incidence of, and risk factors for, liver injury in adults living with human immunodeficiency virus initiating antiretroviral therapy in a South African private sector managed care cohort TI - The incidence of, and risk factors for, liver injury in adults living with human immunodeficiency virus initiating antiretroviral therapy in a South African private sector managed care cohort UR - http://hdl.handle.net/11427/43203 ER - en_ZA
dc.identifier.urihttp://hdl.handle.net/11427/43203
dc.identifier.vancouvercitationSinha S. The incidence of, and risk factors for, liver injury in adults living with human immunodeficiency virus initiating antiretroviral therapy in a South African private sector managed care cohort. []. University of Cape Town ,Faculty of Health Sciences ,Department of Public Health and Family Medicine, 2023 [cited yyyy month dd]. Available from: http://hdl.handle.net/11427/43203en_ZA
dc.language.isoen
dc.language.rfc3066eng
dc.publisher.departmentDepartment of Public Health and Family Medicine
dc.publisher.facultyFaculty of Health Sciences
dc.publisher.institutionUniversity of Cape Town
dc.subjectDrug Safety journal
dc.subjectPharmacoepidemiology
dc.subjectHIV
dc.titleThe incidence of, and risk factors for, liver injury in adults living with human immunodeficiency virus initiating antiretroviral therapy in a South African private sector managed care cohort
dc.typeThesis / Dissertation
dc.type.qualificationlevelMasters
dc.type.qualificationlevelMasters
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
thesis_hsf_2023_sinha suniti.pdf
Size:
4.95 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.72 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Masters